Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

View:
Post by capebretongirl on Jun 22, 2021 11:48am

DOWN

Sad day to see warrants with a .02 cent bid and the ask now at .025.  SZ now at .49 is not reassuring either.

We need a development/announcement here soon.
Comment by IainCaimbeul on Jun 22, 2021 12:21pm
CBG: Five trading days until the AGM, I don't expect anything before that. Aristotle, Aristotle, Aristotle; kind of the old location, location, location for retail outlets and real estate. Still I bought more (small) at $0.50, need my head read. I won't stoop to $0.49 though. :)
Comment by LithLover on Jun 22, 2021 12:24pm
I would expect something tomorrow or Thursday. Picked up more warrants at 0.025.  At 5% of the SP its a no brainer.
Comment by Mykndrsn on Jun 22, 2021 12:35pm
No doubt.
Comment by IainCaimbeul on Jun 22, 2021 12:37pm
Just curious, why tomorrow or Thursday?
Comment by Nailbiter1 on Jun 22, 2021 9:16pm
This post has been removed in accordance with Community Policy
Comment by Liked2Think on Jun 23, 2021 10:58am
Why would any "expect" anything.  Just opens yourself up for massive dissapointment like back in April. There will likely be some fluff piece news release trying to get some life into this thing. Everything will pass that has to be voted on They will close the deal on health clinics  They will say it is "exciting times" and blah blah blah The only thing on aristotle ...more  
Comment by Mykndrsn on Jun 23, 2021 11:06am
More thinking? Don't hurt your brain. 
Comment by SWRB on Jun 22, 2021 1:06pm
This post has been removed in accordance with Community Policy
Comment by IainCaimbeul on Jun 22, 2021 2:50pm
This post has been removed in accordance with Community Policy
Comment by Roberto321 on Jun 22, 2021 4:57pm
This post has been removed in accordance with Community Policy
Comment by Roberto321 on Jun 22, 2021 5:05pm
This post has been removed in accordance with Community Policy
Comment by gojotv! on Jun 22, 2021 5:18pm
This will go up, because profits from Aristotle deployment among Care Oncology patients will show up on the next Q2 financials. Add to that the initial results of Aristotle deployment through Care Oncology's AVRT program in the U.S.... Anyone selling nowadays either needs the cash badlybor is allergic to money... https://www.stagezerolifesciences.com/aristotle.html
Comment by Liked2Think on Jun 23, 2021 11:05am
yes back when we were at 1.60 it wouldnt had been so bad.  Now at 50 cents the market wont like it at all unless Tripp has a massive NR to release with it.  Im talking a big name signing up to use aristotle.  Not some tiny company with a few employees that no one has ever heard about before that we have to buy.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities